Skip to main content
Log in

The biology and pathology of selected skull base tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

This paper describes the pathobiology of some of the more common skull base tumors. In addition to clinicopathologic features, emphasis is placed upon methods of diagnosis utilizing immunoperoxidase stains and molecular markers that may or may not impact upon prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bremer JW, Neel HB III, DeSanto LW, Jones GC: Angio-fibroma: Treatment trends in 150 patients during 40 years. Laryngoscope 96: 1321–1329, 1986

    Google Scholar 

  2. Harrison DFN: The natural history, pathogenesis, and treatment of juvenile angiofibroma. Personal experience with 44 patients. Arch Otolaryngol Head Neck Surg 113: 936–942, 1987

    Google Scholar 

  3. Sarpa JR, Novelly NJ: Extranasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 101: 693–697, 1989

    Google Scholar 

  4. Cummings BJ: Relative risk factors in the treatment of juvenile nasopharyngeal angiofibroma. Head Neck Surg 3: 21–26, 1980

    Google Scholar 

  5. Goepfert H, Cangir A, Lee Y-Y: Chemotherapy for aggressive juvenile nasopharyngeal angiofibroma. Arch Otolaryngol 111: 285–289, 1985

    Google Scholar 

  6. Wit TR, Shah JP, Sternberg SS: Juvenile nasopharyngeal angiofibroma. A 30 year clinical review. Am J Surg 146: 521–525, 1983

    Google Scholar 

  7. Johns ME, MacLeod RM, Cantrell RW: Estrogen receptors in nasopharyngeal angiofibromas. Laryngoscope 90: 628–634, 1980

    Google Scholar 

  8. Lee DA, Rao BR, Meyer JS, Prioleau PG, Bauer WC: Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer 46: 547–551, 1980

    Google Scholar 

  9. Farag MM, Chanimah SE, Ragaie A, Saleem TH: Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope 97: 208–211, 1987

    Google Scholar 

  10. Brentani MM, Butugan O, Oshima CTF, Torloni H, Paiva LJ: Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 99: 398–401, 1989

    Google Scholar 

  11. Gowan AM, Morihara J, Davie P, Donato E, Evans T, Yuan S, Mills SE: Androgen receptor (AR) expression in angiofibromas of the nasopharynx (abstract). Mod Pathol 6: 81A, 1993

    Google Scholar 

  12. Schiff M, Gonzalez A-M, Ong M, Baird A: Juvenile nasopharyngeal angiofibroma contain angiogenic growth factor: Basic FGF. Laryngoscope 102: 940–945, 1992

    Google Scholar 

  13. Barnes L, Weber PC, Krause J, Contis L, Janecka I: Angio-fibroma: A flow cytometric evaluation of 31 cases. Skull Base Surg 2: 195–198, 1992

    Google Scholar 

  14. Makek MS, Andrews JC, Fisch U: Malignant transformation of a nasopharyngeal angiofibroma. Laryngoscope 99: 1088–1092, 1989

    Google Scholar 

  15. Dickson RI: Nasopharyngeal carcinoma: An evaluation of 209 patients. Laryngoscope 91: 333–354, 1981

    Google Scholar 

  16. Simons MJ, Day NE, Wee GB, Shanmugaratnam K, Ho HC, Wong SH, Ti TK, Yong NK, Darmalingam S, de-The G: Nasopharyngeal carcinoma V: Immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. Cancer Res 34: 1192–1195, 1974

    Google Scholar 

  17. Chan SH, Day NE, Khor TH, Kunaratnam N, Chia KB: HLA markers in the development and prognosis of NPC in Chinese. In: Grundmann E, Krueger GRF, Ablashi DV (eds) Nasopharyngeal Carcinoma. Gustav Fischer Verlag, Stuttgart 205–211, 1981

    Google Scholar 

  18. Zhu X, Chen R, Kong F, Liu W: Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China. Ann Otol Laryngol 99: 286–287, 1990

    Google Scholar 

  19. Betuel H, Camoun M, Colombani J, Day NE, Ellouz R, de-The G: The relationship between nasopharyngeal carcinoma and the HLA system among Tunisians. Int J Cancer 16: 249–254, 1975

    Google Scholar 

  20. Moore SB, Pearson GR, Neel HB III, Weiland LH: HLA and nasopharyngeal carcinoma in North American Caucasoids. Tissue Antigens 22: 72–75, 1983

    Google Scholar 

  21. Lanier A, Bender T, Talbot M, Wilmeth S, Tschopp C, Henle W, Henle G, Ritter D, Terasaki P: Nasopharyngeal carcinoma in Alaskan Eskimos, Indians, and Aleuts: A review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors. Cancer 46: 2100–2106, 1980

    Google Scholar 

  22. Raab-Traub N, Flynn K, Pearson G, Huang A, Levine P, Lanier A, Pagano J: The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 39: 25–29, 1987

    Google Scholar 

  23. Hawkins EP, Krischer JP, Smith BE, Hawkins HK, Finegold MJ: Nasopharyngeal carcinoma in children — A retrospective review and demonstration of Epstein-Barr viral genomes in tumor cell cytoplasm: A report of the Pediatric Oncology Group. Hum Pathol 21: 805–810, 1990

    Google Scholar 

  24. Neel HB III, Taylor WF: Epstein-Barr virus-related anti-body. Changes in titers after therapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 116: 1287–1290, 1990

    Google Scholar 

  25. Lung ML, Sham JST, Lam WP, Choy DTK: Analysis of Epstein-Barr virus in localized nasopharyngeal carcinoma tumors. Cancer 71: 1190–1192, 1993

    Google Scholar 

  26. Zur Hausen H, Schulte-Hosthausen H, Klein G: EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228: 1056–1058, 1970

    Google Scholar 

  27. Huang DP, Ho HC, Henle G: Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology. Int J Cancer 22: 266–274, 1978

    Google Scholar 

  28. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE: Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 43: 2967–2970, 1983

    Google Scholar 

  29. Sham JST, Choy D: Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Br J Radiol 63: 51–58, 1990

    Google Scholar 

  30. Skinner DW, Van Haslett CA, Tsao SY: Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol 100: 549–551, 1991

    Google Scholar 

  31. Sham JST, Cheung YK, Choy D, Chan FL, Leong L: Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma. Cancer 68: 422–426, 1991

    Google Scholar 

  32. Gustafson RO, Neel HB III: Cancer of the nasopharynx. In: Myers EN, Suen JY (eds) Cancer of the Head and Neck, 2nd ed, Churchill Livingston 495–508, 1989

    Google Scholar 

  33. Ahmad A, Stefani S: Distant metastases of nasopharyngeal carcinoma: A study of 256 patients. J Surg Oncol 33: 194–197, 1981

    Google Scholar 

  34. Vikram B, Mishra UB, Strong EW, Manolatos S: Patterns of failure in carcinoma of the nasopharynx: Failure at distant sites. Head Neck Surg 8: 276–279, 1986

    Google Scholar 

  35. Feinmesser R, Feinmesser M, Freeman JL, Noyek AM, Livni N: Detection of occult nasopharyngeal primary tumours by means ofin situ hybridization. J Laryngol Otol 106: 345–348, 1992

    Google Scholar 

  36. Feinmesser R, Miyazakai I, Cheung R, Freeman JL, Noyek AM, Dosch H-M: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 326: 17–21, 1992

    Google Scholar 

  37. Shanmugaratnam K, Sobin L: Histologic Typing of Upper Respiratory Tract Tumors. International Typing of Tumours No. 19. World Health Organization, Geneva, 1978

    Google Scholar 

  38. Shanmugaratnam K, Sobin L: Histological Typing of Tumours of the Upper Respiratory Tract and Ear. International Histological Classification of Tumours, 2nd. ed., Springer-Verlag, Berlin, 1991

    Google Scholar 

  39. Weiland LH: Nasopharyngeal carcinoma. In: Barnes L (ed) Surgical Pathology of the Head and Neck, Marcel Dekker Inc, New York 453–466, 1985

    Google Scholar 

  40. Shanmugaratnam K, Chan SH, de-The G, Goh JEH, Khor TH, Simons MJ, Tye CY: Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics. Cancer 44: 1029–1044, 1979

    Google Scholar 

  41. Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF Jr, Cooper PH, Colby TV, Mills SE: Analysis of lymphoepithelioma-like carcinoma for Epstein-Barr viral genomes byin-situ hybridization. Am J Surg Pathol 13: 625–631, 1989

    Google Scholar 

  42. Akoa I, Sato Y, Mukai K, Uhara H, Furuya S, Hoshikawa T, Shimosato Y, Takeyama I: Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction andin situ hybridization. Laryngoscope 101: 279–283, 1991

    Google Scholar 

  43. Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T: Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 57: 100–105, 1986

    Google Scholar 

  44. Hsu M-M, Hsu H-C, Lui LT: Local immune reaction in nasopharyngeal carcinoma, with special reference to its prognostic evaluation. Head Neck 11: 505–510, 1989

    Google Scholar 

  45. Cheng DS, Campbell BH, Clowry LJ, Hopwood LE, Murray KJ, Toohill RJ, Hoffman RG: DNA content in naso-pharyngeal carcinoma. Am J Otolaryngol 11: 393–397, 1990

    Google Scholar 

  46. Costello F, Mason BR, Collins RJ, Kearsley JH: A clinical and flow cytometric analysis of patients with nasopharyngeal carcinoma. Cancer 66: 1789–1795, 1990

    Google Scholar 

  47. Neel HB III, Taylor WF, Pearson GR: Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 94: 529–537, 1985

    Google Scholar 

  48. Cooper JS, Scott C, Marcial V, Griffin T, Fazekas J, Laramore G, Hoffman A: The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy and Oncology Group. Cancer 67: 1673–1677, 1991

    Google Scholar 

  49. Singh P, Ilancheran A, Ratnam SS, Kim L-TS, O'Reilly AP: Cervical adenocarcinoma in women with nasopharyngeal carcinoma (NPC). Cancer 64: 1152–1155, 1989

    Google Scholar 

  50. Kavanagh BD, Halperin EC, Rosenbaum LC, Shannon EM, Nilaver G: Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer 69: 1315–1319, 1992

    Google Scholar 

  51. Choi PHK, Suen MWM, Huang DP, Lo K-W, Lee JC: Nasopharyngeal carcinoma: Genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer 72: 2873–2878, 1993

    Google Scholar 

  52. Cianfriglia F, Pompili A, Occhipinti E: Intracranial malignant cartilaginous tumours. Report of two cases and review of the literature. Acta Neurochirurgica 45: 163–175, 1978

    Google Scholar 

  53. Bahr AL, Gayler BW: Cranial chondrosarcomas. Report of four cases and review of the literature. Radiology 124: 151–156, 1977

    Google Scholar 

  54. Hassounah M, Al-Mefty O, Akhtar M, Jinkins JR, Fox JL: Primary cranial and intracranial chondrosarcoma. A survey. Acta Neurochirurgica 78: 123–132, 1985

    Google Scholar 

  55. Kveton JF, Brackman DE, Glasscock ME III, House WF, Hitselberger WE: Chondrosarcoma of the skull base. Otolaryngol Head Neck Surg 94: 23–32, 1986

    Google Scholar 

  56. Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R, Birbaum S, Ruotolo D, McManus P, Skates S, Ojemann RG, Rosenberg A, Schiller A, Koehler A, Suit HD: Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 70: 13–17, 1989

    Google Scholar 

  57. Morimoto T, Sasaki T, Tokakura K, Ishida T: Chondrosarcoma of the skull base: Report of six cases. Skull Base Surg 2: 177–185, 1992

    Google Scholar 

  58. Adegbite ABO, McQueen JD, Paine KWE, Rozdilsky B: Primary intracranial chondrosarcoma: A report of two cases. Neurosurgery 17: 490–494, 1985

    Google Scholar 

  59. Grossman RI, Davis KR: Cranial computed tomographic appearance of chondrosarcoma of the base of the skull. Radiology 141: 403–108, 1981

    Google Scholar 

  60. Sen CN, Sekhar LN, Schramm VL, Janecka IP: Chordoma and chondrosarcoma of the cranial base: An 8-year experience. Neurosurgery 25: 931–941, 1989

    Google Scholar 

  61. Evans HL, Ayala AG, Romsdahl MM: Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40: 818–831, 1977

    Google Scholar 

  62. Kreicbergs A, Boquist L, Boxssen B, Larsson S-E: Prognostic factors in chondrosarcoma. A comparative study of cellular DNA content and clinicopathologic features. Cancer 50: 577–583, 1982

    Google Scholar 

  63. Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F: Chromosomal rearrangements in chondromatous tumors. Cancer 65: 242–248, 1990

    Google Scholar 

  64. Wright D: Nasopharyngeal and cervical chordoma — some aspects of their development and treatment. J Laryngol Otol 81: 1337–1355, 1967

    Google Scholar 

  65. Huvos AG: Chordoma. In: Huvos AG (ed) Bone Tumors. Diagnosis, Treatment and Prognosis, 2nd ed., WB Saunders, Philadelphia 599–624, 1991

    Google Scholar 

  66. Heffelfinger MJ, Dahlin DC, MacCarty SS, Beabout JW: Chordomas and cartilaginous tumors at the skull base. Cancer 32: 410–420, 1973

    Google Scholar 

  67. Raffel C, Wright DC, Gutin PH, Wilson CB: Cranial chordomas: clinical presentation and results of operative and radiation therapy in twenty-six patients. Neurosurgery 17: 703–709, 1985

    Google Scholar 

  68. Meyer JE, Oot RF, Lindfors KK: CT appearance of clival chordomas. J Comput Assist Tomogr 10: 34–38, 1986

    Google Scholar 

  69. Wold LE, Laws ER Jr: Cranial chordomas in children and young adults. J Neurosurg 59: 1043–1047, 1983

    Google Scholar 

  70. Oot RF, Melville GE, New PFJ, Austin-Seymour M, Munzenrider J, Pile-Spellman J, Spagnoli M, Shoukimas GM, Momose KJ, Carroll R, Davis KR: The role of MR and CT in evaluating clival chordomas and chondrosarcomas. AJR 151: 567–575, 1988

    Google Scholar 

  71. O'Neill P, Bell BA, Miller JD, Jacobson I, Guthrie W: Fifty years of experience with chordomas in Southeast Scotland. Neurosurgery 16: 166–170, 1985

    Google Scholar 

  72. Crumley RL, Gutin PH: Surgical access for clivus chordoma. Arch Otolaryngol Head Neck Surg 115: 295–300, 1989

    Google Scholar 

  73. Harbour JW, Lawton MT, Criscuolo GR, Holliday MJ, Mattox DE, Long DM: Clivus chordoma: A report of 12 recent cases and review of the literature. Skull Base Surg 1: 200–206, 1991

    Google Scholar 

  74. Chambers PW, Schwinn CP: Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol 72: 765–776, 1979

    Google Scholar 

  75. Coffin CM, Swanson PE, Wick MR, Dehner LP: Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med 117: 927–933, 1993

    Google Scholar 

  76. Wold LE, Laws ER Jr: Cranial chordomas in children and young adults. J Neurosurg 59: 1043–1047, 1983

    Google Scholar 

  77. Hruban RH, Tragnanos F, Reuter VE, Huvos AG: Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications. Am J Pathol 137: 435–447, 1990

    Google Scholar 

  78. Chu T-A: Chondroid chordoma of the sacrococcygeal region. Arch Pathol Lab Med 111: 861–864, 1987

    Google Scholar 

  79. Volpe R, Mazabraud A: A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol 7: 161–170, 1983

    Google Scholar 

  80. Rich TA, Schiller A, Suit HD, Mankin JH: Clinical and pathologic review of 48 cases of chordoma. Cancer 56: 182–187, 1985

    Google Scholar 

  81. Perzin KH, Pushparaj NL: Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinico-pathologic study. XIV: Chordomas. Cancer 57: 784–796, 1986

    Google Scholar 

  82. Brooks JJ, Livolsi VA, Trojanowski JQ: Does chondroid chordoma exist? Acta Neuropathologica 72: 229–235, 1987

    Google Scholar 

  83. Wojno KJ, Hurban RH, Garin-Chesa P, Huvos AG: Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Am J Surg Pathol 16: 1144–1152, 1992

    Google Scholar 

  84. Miettinen M, Karaharju E, Jarvinen H: Chordoma with a massive spindle-cell sarcomatous transformation. A light- and electron-microscopic and immunohistochemical study. Am J Surg Pathol 11: 563–570, 1987

    Google Scholar 

  85. Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA: ‘Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol 11: 516–525, 1987

    Google Scholar 

  86. Fleming GF, Heimann PS, Stephens JK, Simon MA, Ferguson MK, Benjamin RS, Samuels BL: Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 72: 714–718, 1993

    Google Scholar 

  87. Al-Mefty O (ed): Meningiomas. Raven Press Ltd, NewYork 37–57, 1991

    Google Scholar 

  88. Barnes L, Peel RL, Verbin R: Tumors of the nervous system. In: Barnes L (ed) Surgical Pathology of the Head and Neck, Marcel Dekker, Inc, New York, New York 659–724, 1985

    Google Scholar 

  89. Gagon NB, Lavigne F, Mohr G,et al.: Extracranial and intracranial meningiomas. J Otolaryngol 15: 380–384, 1986

    Google Scholar 

  90. Kepes JJ: Meningioma — Biology, Pathology and Differential Diagnosis, Masson Publishing Inc, Philadelphia, USA, 1982

    Google Scholar 

  91. Winek RR, Scheithauer BW, Wick MR: Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma and acoustic schwannoma. Am J Surg Pathol 13: 251–261, 1989

    Google Scholar 

  92. Nager GT, Heroy J, Hoeplinger M: Meningiomas invading the temporal bone with extension to the neck. Am J Otolaryngol 4: 197–324, 1983

    Google Scholar 

  93. Goellner JR, Laws ER, Soule EH,et al.: Hemangiopericytoma of the meninges. Mayo Clinic experience. Am J Clin Pathol 70: 375–380, 1978

    Google Scholar 

  94. Holden J, Dolman CL, Churg A: Immunohistochemistry of intracranial meningiomas including angioblastic type. J Neuropathol Exp Neurol 46: 50–56, 1987

    Google Scholar 

  95. Meis JM, Ordonez NG, Bruner JM: Meningiomas. An immunohistochemical study of 50 cases. Arch Pathol Lab Med 110: 934–937, 1986

    Google Scholar 

  96. Radley MG, Sant'Agnese AD, Eskin TA,et al.: Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study with review of the literature. Am J Surg Pathol 92: 226–272, 1989

    Google Scholar 

  97. Schnitt SJ, Vogel H: Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol 10: 640–649, 1986

    Google Scholar 

  98. Suster S, Rosai J: Hamartoma of the scalp with ectopic meningothelial elements. A distinctive benign soft tissue lesion that may simulate angiosarcoma. Am J Surg Pathol 14: 1–14, 1990

    Google Scholar 

  99. Thomas HG, Dolman CI, Berry K: Malignant meningiomas: clinical and pathological features. J Neurosurg 55: 929–934, 1981

    Google Scholar 

  100. Friedman CD, Costantino PD, Teitelbaum B,et al.: Primary extracranial meningiomas of the head and neck. Laryngoscope 100: 41–48, 1990

    Google Scholar 

  101. Batsakis JG: Extracranial meningiomas. Ann Otol Rhinol Laryngol 93: 282–283, 1984

    Google Scholar 

  102. Manni JJ; Ectopic meningioma of the maxillary sinus. J Laryngol Otol 97: 657–660, 1983

    Google Scholar 

  103. Perzin KH, Pushparaj N: Nonepithelial tumors of the nasal cavity, paranasal sinuses, nasopharynx. A clinicopathologic study. XIII: Meningiomas. Cancer 54: 1860–1869, 1984

    Google Scholar 

  104. Salama N, Stafford N: Meningiomas presenting in the middle ear. Laryngoscope 92: 92–97, 1982

    Google Scholar 

  105. Taxy JB: Meningioma of the paranasal sinuses. A report of two cases. Am J Surg Pathol 14: 82–86, 1990

    Google Scholar 

  106. Cahill DW, Bashirelahi N, Solomon LW,et al: Estrogen and progesterone receptors in meningiomas. J Neurosurg 60: 985–993, 1984

    Google Scholar 

  107. Lesch K-P, Gross SG: Estrogen receptor immunoreactivity in meningiomas. Comparison with the binding activity of estrogen, progesterone, and androgen receptors. J Neurosurg 67: 237–243, 1987

    Google Scholar 

  108. Casalone R, Simi P, Granata P,et al.: Correlation between cytogenetic and histopathologic findings in 65 human meningiomas. Cancer Genet Cytogenet 45: 237–243, 1990

    Google Scholar 

  109. Jones NR, Rossi ML, Gregoriou M,et al: Epidermal growth factor receptor expression in 72 meningiomas. Cancer 66: 152–155, 1990

    Google Scholar 

  110. Shiurba RA, Eng LF, Vogel H,et al. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells. Cancer 62: 2139–2144, 1988

    Google Scholar 

  111. Salmon I, Kiss R, Lavivier M,et al: Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors. Am J Surg Pathol 17: 239–247, 1993

    Google Scholar 

  112. Ironside JW, Battersby RDE, Lawry J,et al: DNA in meningioma tissues and expiant cell cultures: a flow cytometric study with clinicopathologic correlates. J Neurosurg 66: 588–594, 1987

    Google Scholar 

  113. Hoshino T, Nagashima T, Murovic JA,et al.: Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 58: 1466–1472, 1986

    Google Scholar 

  114. Korkolopoulou P, Christodoulou A, Papanikolaou A, Thomas-Tsagli E: Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. Am J Surg Pathol 17: 912–919, 1993

    Google Scholar 

  115. Patsouris E, Stocker U, Kallmeyer V,et al.: Relationship between Ki-67 positive cells, growth rate and histologic type of human intracranial tumors. Anticancer Res 8: 537–544. 1988

    Google Scholar 

  116. Roggendorf W, Schuster T, Peiffer J: Proliferative potential of meningiomas determined with the monoclonal anti-body Ki-67. Acta Neuropathol (Berl) 73: 361–364, 1987

    Google Scholar 

  117. Fukui M, Iwaki T, Sawa H,et al: Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir (Wien) 81: 135–141, 1986

    Google Scholar 

  118. Scheithauer BW: Surgical Pathology of the Pituitary: The adenomas (Parts 1 and 2). Pathol Annu 19: 269–329, and 317–374, 1984

    Google Scholar 

  119. Scheithauer BW: The anterior pituitary hormones with special reference to the immunocytology of pituitary adenomas and neuroendocrine neoplasms. In: Wick MR, Seigal GP (eds) Monoclonal Antibodies in Diagnostic Immunohistochemistry, Marcel Dekker, New York, 1988

    Google Scholar 

  120. Kovacs K, Horvath E: Tumors of the pituitary gland. In: Atlas of Tumor Pathology, 2nd Series, Fascicle 21, Washington, DC, Armed Forces Institute of Pathology, 1986

    Google Scholar 

  121. Martinez AJ, Lee A, Moossy J, Maroon JC: Pituitary adenomas: Clinico-pathologic and immunohistochemical study. Ann Neurol 7: 24–36, 1980

    Google Scholar 

  122. Challa VR, Marshall RB, Hopkins MB,et al.: Pathobiologic study of pituitary tumors: report of 62 cases with a review of the recent literature. Hum Pathol 16: 873–884, 1985

    Google Scholar 

  123. Anand VK, Osborne CM, Harkey L: Infiltrative clival pituitary adenoma of ectopic origin. Otolaryngol Head Neck Surg 108: 178–183, 1993

    Google Scholar 

  124. Chessin H, Urdaneta N, Smith H, Gilder JV: Chromo-phobe adenoma manifesting as a nasopharyngeal mass. Arch Otolaryngol 102: 631–633, 1976

    Google Scholar 

  125. Cole IE, Keene M: Nasal obstruction in pituitary tumors. J Laryngol Otol 95: 183–189, 1981

    Google Scholar 

  126. Davis JM, Weber AL: Pituitary adenoma presenting as a sphenoid sinus lesion. Ann Otol Rhinol Laryngol 89: 483–484, 1980

    Google Scholar 

  127. Dent JA, Rickhuss PK: Invasive pituitary adenoma presenting with nasal obstruction. J Laryngol Otol 103: 605–609, 1989

    Google Scholar 

  128. Scheithauer BW, Kovacs K, Laws ER, Randall RV: Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733–744, 1986

    Google Scholar 

  129. Alexander JM, Biller BMK, Bikkal H,et al.: Clinically non-functioning pituitary tumors are monoclonal in origin. J Clin Invest 86: 336–340, 1990

    Google Scholar 

  130. Black PM, Hus DW, Klibanski A,et al.: Hormone production in clinically non-functioning pituitary adenomas. J Neurosurg 66: 244–250, 1987

    Google Scholar 

  131. Flickinger JC, Nelson PB, Martinez AJ,et al: Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63: 2409–2414, 1989

    Google Scholar 

  132. Martinez AJ: The pathology of nonfunctional pituitary adenomas. Semin Diagn Pathol 3: 83–94, 1986

    Google Scholar 

  133. Kovacs K, Horvath E, Ryan N,et al.: Null cell adenoma of the human pituitary. Virchows Archiv [A] Pathol Anat 387: 165–174, 1980

    Google Scholar 

  134. Lloyd RV, Chandler WF, Kovacs K, Ryan N: Ectopic pituitary adenomas with normal pituitary glands. Am J Surg Pathol 10: 546–552, 1986

    Google Scholar 

  135. Mukai K: Pituitary adenomas. Immunocytochemical study of 150 tumors with clinicopathologic correlation. Cancer 52: 648–653, 1983

    Google Scholar 

  136. Scheithauer BW, Randall RV, Laws ERJ,et al: Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer 55: 598–604, 1985

    Google Scholar 

  137. Lloyd RV, Cano M, Chandler WF,et al: Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization. Am J Pathol 134: 605–613, 1989

    Google Scholar 

  138. Levy A, Lightman SL: Quantitativein-situ hybridization histochemistry of anterior pituitary hormone mRNA species in human pituitary adenomas. Acta Endocrinol 119: 397–404, 1988

    Google Scholar 

  139. Fitzgibbons PL, Appley AJ, Turner RR,et al.: Flow cytometry analysis of pituitary tumors. Correlation of nuclear antigen pl05 and DNA content with clinical behavior. Cancer 62: 1156–1560, 1988

    Google Scholar 

  140. McNicol AM, Shepherd M, Lane DP: Cell proliferation in pituitary adenomas: corrrelation with hormonal immuno-reactivity. J Endocrinol Invest 14 (Suppl 1): 1991A, 1991

    Google Scholar 

  141. Nagashima T, Murovic JA, Hoshino T,et al.: The proliferative potential of human pituitary tumorsin situ. J Neuro-surg 64: 588–593, 1986

    Google Scholar 

  142. Herman V, Fagin J, Gonskyet al.: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427–1433, 1990

    Google Scholar 

  143. Landis CA, Masters SB, Spada A, et al: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427–1433, 1990

    Google Scholar 

  144. Karga HJ, Alexander JM, Hedley-Whyte ET,et al: Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74: 914–919, 1992

    Google Scholar 

  145. Stefaneanu L, Horvath E, Kovacs K: Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary. Mod Pathol 2: 192–199, 1989

    Google Scholar 

  146. Appelblatt NH, McClatchey KD: Olfactory neuroblastoma: A retrospective clinicopathologic study. Head Neck Surg 5: 108–113, 1982

    Google Scholar 

  147. Baker DC, Perzin KH, Conley J: Olfactory neuroblastoma. Otolaryngol Head Neck Surg 87: 279–283, 1979

    Google Scholar 

  148. Barnes L, Peel RL, Verbin RS: Tumors of the nervous system. In: Barnes L (ed) Surgical Pathology of the Head and Neck, Vol 1, Marcel Dekker, Inc, New York 659–724, 1985

    Google Scholar 

  149. Dulguerov P, Calcaterra T: Esthesioneuroblastoma: The UCLA experience 1970–1990. Laryngoscope 102: 843–849, 1992

    Google Scholar 

  150. Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC: Esthesioneuroblastoma. Cancer 44: 1087–1094, 1979

    Google Scholar 

  151. Harrison D: Surgical pathology of olfactory neuroblastoma. Head Neck Surg 7: 60–64, 1984

    Google Scholar 

  152. Hyams VJ, Batsakis JG, Michaels L: Tumors of the Upper Respiratory Tract and Ear. Atlas of Tumor Pathology, Armed Forces Institute of Pathology, 1988

  153. Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37: 1571–1576, 1976

    Google Scholar 

  154. Lewis JE, Morita A, Ebersold MJ: Grading and prognosis of olfactory neuroblastoma. Mod Pathol 6: 82A, 1993

    Google Scholar 

  155. Lund VJ, Milroy C: Olfactory neuroblastoma: clinical and pathological aspects. Rhinology 31: 1–6, 1993

    Google Scholar 

  156. Mills SE, Frierson HF Jr: Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol 9: 317–327, 1985

    Google Scholar 

  157. Olsen KD, DeSanto LW: Olfactory neuroblastoma. Biologic and clinical behavior. Arch Otolaryngol 109: 797–802, 1983

    Google Scholar 

  158. Taxy JB, Bharani NK, Mills SE,et al: The spectrum of olfactory neural tumors. A light-microscopic, immunohisto-chemical, and ultrastructural analysis. Am J Surg Pathol 10: 687–695, 1986

    Google Scholar 

  159. Taxy JB, Hidvegi DF: Olfactory neuroblastoma. An ultra-structural study. Cancer 39: 131–138, 1977

    Google Scholar 

  160. Nakashima T, Kimmelman CP, Snow JB Jr: Structure of human fetal and adult olfactory neuroepithelium. Arch Otolaryngol 110: 641–646, 1984

    Google Scholar 

  161. Schmidt JL, Zarbo RJ, Clark JL: Olfactory neuroblastoma: clinicopathologic and immunohistochemical characterization of four representative cases. Laryngoscope 100: 1052–1058, 1990

    Google Scholar 

  162. Axe S, Kuhajda FP: Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens. Am J Clin Pathol 88: 139–145, 1987

    Google Scholar 

  163. Choi H-S, Anderson PJ: Immunohistochemical diagnosis of olfactory neuroblastoma. J Neuropathol Exp Neurol 44: 18–31, 1985

    Google Scholar 

  164. Frierson HF, Ross GW, Mills SE,et al: Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol 94: 547–553, 1990

    Google Scholar 

  165. Trojanowski JQ, Lee V, Pillsbury N,et al.: Neuronal origin of human esthesioneuroblastoma demonstrated with anti-neurofilament monoclonal antibodies. N Eng J Med 307: 159–161, 1982

    Google Scholar 

  166. Barnes L, Peel RL: Olfactory neuroblastomas versus sinonasal undifferentiated carcinoma. In: Head and Neck Pathology. A Text/Atlas of Differential Diagnosis, Igaku-Shoin, New York 152–154, 1990

    Google Scholar 

  167. Baugh RF, Wolf GT, McClatchey KD: Small cell carcinoma of the head and neck. Head Neck Surg 8: 343–354, 1986

    Google Scholar 

  168. Frierson HF, Mills SE, Fechner RE,et al. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from Schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 10: 771–779, 1986

    Google Scholar 

  169. Kameya T, Shimosato Y, Adachi I,et al.: Neuroendocrine carcinoma of the paranasal sinus. A morphological and endocrinological study. Cancer 45: 330–339, 1980

    Google Scholar 

  170. Mills SE, Fechner RE: Differentiated neoplasms of the sinonasal region: Differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Semin Diag Pathol 6: 316–328, 1989

    Google Scholar 

  171. Silva EG, Butler JJ, Mackay B, Goepfert H: Neuroblastoma and neuroendocrine carcinomas of the nasal cavity. A proposed new classification. Cancer 50: 2388–2405, 1982

    Google Scholar 

  172. Stephenson CF, Bridge JA, Sandberg AA. Cytogenetic and pathogenetic aspects of Ewing's sarcoma and neuroecto-dermal tumors. Hum Pathol 23: 1270–1277, 1992

    Google Scholar 

  173. Whang-Peng J, Freter CE, Knutsen T,et al: Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 29: 155–157, 1987

    Google Scholar 

  174. Wenig B, Hitchcock C, Griffin J, Heffner D: Olfactory esthesioneuroblastoma: Support for a grading system based on flow cytometric and histopathologic correlation. Mod Pathol 3: 65A, 1990 (abstract)

    Google Scholar 

  175. Schwartz MR, Hicks MJ, SeGall GK, Donovan DT: Flow cytometric analysis of olfactory neuroblastomas and high grade olfactory neuroendocrine carcinomas. Mod Pathol 6: 83A, 1993

    Google Scholar 

  176. Zappia JJ, Carroll WR, Wolf GT, Thornton AF, Ho L, Krause CJ: Olfactory neuroblastoma: The results of modern treatment approaches at the University of Michigan. Head Neck 15: 190–196, 1993

    Google Scholar 

  177. Gould VE, Sommers SC: The adrenal medulla and para-ganglia. In: Bloodworth (ed) Endocrine Pathology, General and Surgical, second edition, Williams and Wilkins, Baltimore 497–511, 1982

    Google Scholar 

  178. Glenner GG, Grimley PM: Tumors of the Extra-adrenal Paraganglion System (Including Chemoreceptors). Atlas of Tumor Pathology, Armed Forces Institute of Pathology, fascicle 9, second series, 1974

  179. Barnes L, Taylor S: Carotid body paragangliomas: a clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol 116: 447–453, 1990

    Google Scholar 

  180. Barnes L, Taylor S: Vagal paragangliomas: a clinical, pathological and DNA assessment. Clin Otolaryngol 16: 376–382, 1991

    Google Scholar 

  181. Brown JS: Glomus jugulare tumors revisited: A ten-year statistical follow up of 231 cases. Laryngoscope 95: 284–288, 1985

    Google Scholar 

  182. Erikson C, Girdhar-Gopal H, Lowry LD: Vagal paragangliomas: A report of nine cases. Am J Otolaryngol 12: 278–287, 1991

    Google Scholar 

  183. Kliewer KE, Wen DR, Cancilla PA, Cochran AJ: Paragangliomas: assessment of prognosis by histologic, immuno-histochemical, and ultrastructural techniques. Hum Pathol 20: 29–39, 1989

    Google Scholar 

  184. Kliewer KE, Cochran AJ: A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 113: 1209–1218, 1989

    Google Scholar 

  185. Lack EE, Cubilla AL, Woodruff JM: Paragangliomas of the head and neck region. A clinical study of 69 patients. Cancer 39: 397–409, 1977

    Google Scholar 

  186. Lack EE, Cubilla AL, Woodruff JM: Paragangliomas of the head and neck region. A pathologic study of tumors from 70 patients. Hum Pathol 10: 191–218, 1979

    Google Scholar 

  187. Moore G, Yarington CT, Mangham CA: Vagal body tumors: Diagnosis and treatment. Laryngoscope 96: 533–536, 1986

    Google Scholar 

  188. Johnstone PAS, Foss RD, Desilets DJ: Malignant jugulo-tympanic paraganglioma. Arch Pathol Lab Med 114: 976–979, 1990

    Google Scholar 

  189. Martinez-Madrigal F, Bosq J, Micheau C, Nivet P, Luboinski B: Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuroendocrine carcinomas. Pathol Res Prac 187: 814–823, 1991

    Google Scholar 

  190. Warren WH, Lee I, Gould VE,et al.: Paragangliomas of the head and neck: Ultrastructural and immunohistochemical analysis. Ultrastructural Pathol 8: 333–343, 1985

    Google Scholar 

  191. Nadji M, Albores-Saavedra J, Ziegels-Weissman J, Morales AR: Antigenic profile of benign, locally invasive, and metastatic paragangliomas. Lab Invest 54: 46A, 1986

    Google Scholar 

  192. Schroder HD, Johannsen L: Demonstration of S-100 protein in sustentacular cells of pheochromocytomas and paragangliomas. Histopathology 10: 1023–1033, 1986

    Google Scholar 

  193. Achilles E, Padberg BC, Holl K, Kloppel G, Schroder S: Immunocytochemistry of paragangliomas-value of staining for S-100 protein and glial fibrillary acidic protein in diagnosis and prognosis. Histopathology 18: 453–458, 1991

    Google Scholar 

  194. Jackson CG, Harris PF, Glasscock ME, Fritsch M, Dimitrov E, Johnson GD, Poe DS: Diagnosis and management of paragangliomas of the skull base. Am J Surg 159: 389–393, 1990

    Google Scholar 

  195. Kimura N, Miura Y, Nagatsu I, Nagura H: Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning pheochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat 421: 25–32, 1992

    Google Scholar 

  196. Kremer R, Michel RP, Posner B, Wang NS, Lafond GP, Crawhall JC: Catecholamine-secreting paraganglioma of glomus jugulare region. Am J Med Science 297: 46–48, 1989

    Google Scholar 

  197. Sobol SM, Dailey JC: Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 102: 382–390, 1990

    Google Scholar 

  198. Jovanovic R, Hacker GW, Falkmer UG, Falkmer S, Mendel L, Graf AH, Hoog A, Kanjuh V, Silfversward C, Grimelieu L: Paragangliomas: neuroendocrine features and cytometric DNA distribution patterns. A clinicopathological study of 22 cases. Virchows Arch-A, Pathol Anat Histopathol 419: 455–461, 1991

    Google Scholar 

  199. Van der Mey AG, Cornelisse CJ, Hermans J, Terpstra JL, Schmidt PH, Fleuren GJ: DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumors). Brit J Cancer 63: 298–302, 1991

    Google Scholar 

  200. Granger JK, Houn HY: Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis. South Med J 83: 1407–1412, 1990

    Google Scholar 

  201. Gee MS, Kliewer KE, Hinton DR: Nucleolar organizer regions in paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg 118: 380–383, 1992

    Google Scholar 

  202. Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E, Lamberts S:In vitro andin vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 74: 1082–1089, 1992

    Google Scholar 

  203. Suzuki T, Watanabe K, Sugino T,et al.: Immunocytochemical demonstration of IGF-II immunoreactivity in human phaeochromocytoma and extra-adrenal abdominal para-ganglioma. J Pathol 167: 199–203, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnes, L., Kapadia, S.B. The biology and pathology of selected skull base tumors. J Neuro-Oncol 20, 213–240 (1994). https://doi.org/10.1007/BF01053041

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01053041

Key words

Navigation